Seitler, S; Zuhair, M; Shamsi, A; Bray, JJH; Wojtaszewska, A; Siddiqui, A; Ahmad, M; ... Akhtar, A; + view all Seitler, S; Zuhair, M; Shamsi, A; Bray, JJH; Wojtaszewska, A; Siddiqui, A; Ahmad, M; Fairley, J; Providencia, R; Akhtar, A; - view fewer (2023) Cardiac imaging in rheumatic heart disease and future developments. European Heart Journal Open , 3 (2) , Article oeac060. 10.1093/ehjopen/oeac060.

Preview

Text Seitler 2023 EHJO.pdf - Published Version Download (363kB) | Preview

Abstract

Rheumatic heart disease (RHD) is the most common cause of valvular heart disease worldwide, affecting millions, especially in low-and middle-income countries. Multiple imaging modalities such as cardiac CT, cardiac MRI, and three-dimensional echocardiography may be utilized in diagnosing, screening, and managing RHD. However, two-dimensional transthoracic echocardiography remains the cornerstone of imaging in RHD. Criteria developed by the World Heart Foundation in 2012 sought to unify the diagnostic imaging criteria for RHD, but concerns remain regarding their complexity and reproducibility. In the intervening years, further measures have been developed to find a balance between simplicity and accuracy. Nonetheless, there remain significant unresolved problems within imaging in RHD, including the development of a practical and sensitive screening tool to identify patients with RHD. The emergence of handheld echocardiography has the potential to revolutionize RHD management in resource-poor settings, but its role as a screening or diagnostic tool is yet to be fully established. The dramatic evolution of imaging modalities over the last few decades has not addressed RHD compared to other forms of structural heart disease. In this review, we examine the current and latest developments concerning cardiac imaging and RHD.

Download activity - last month

Export as XMLCSVJSON

Download activity - last 12 months

Export as CSVXMLJSON

Downloads by country - last 12 months

Export as CSVXMLJSON

Archive Staff Only

View Item